国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Amia calva 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (prhoxnb) CSB-YP607308AIW
CSB-EP607308AIW
CSB-BP607308AIW
CSB-MP607308AIW
CSB-EP607308AIW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyra haitanensis C-phycocyanin alpha chain (cpcA) CSB-YP607309PBAB
CSB-EP607309PBAB
CSB-BP607309PBAB
CSB-MP607309PBAB
CSB-EP607309PBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyra haitanensis R-phycoerythrin beta chain (cpeB) CSB-YP607310PBAB
CSB-EP607310PBAB
CSB-BP607310PBAB
CSB-MP607310PBAB
CSB-EP607310PBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera NAD (P)H-quinone oxidoreductase subunit H, chloroplastic (ndhH) CSB-YP607311VFQ
CSB-EP607311VFQ
CSB-BP607311VFQ
CSB-MP607311VFQ
CSB-EP607311VFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera NAD (P)H-quinone oxidoreductase chain 4, chloroplastic (ndhD), partial CSB-YP607312VFQ
CSB-EP607312VFQ
CSB-BP607312VFQ
CSB-MP607312VFQ
CSB-EP607312VFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera 30S ribosomal protein S3, chloroplastic (rps3) CSB-YP607313VFQ
CSB-EP607313VFQ
CSB-BP607313VFQ
CSB-MP607313VFQ
CSB-EP607313VFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera 50S ribosomal protein L36, chloroplastic (rpl36) CSB-YP607314VFQ
CSB-EP607314VFQ
CSB-BP607314VFQ
CSB-MP607314VFQ
CSB-EP607314VFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera Photosystem II reaction center protein H (psbH), partial CSB-YP607315VFQ1
CSB-EP607315VFQ1
CSB-BP607315VFQ1
CSB-MP607315VFQ1
CSB-EP607315VFQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera 30S ribosomal protein S12, chloroplastic (rps12-A) CSB-YP607316VFQ
CSB-EP607316VFQ
CSB-BP607316VFQ
CSB-MP607316VFQ
CSB-EP607316VFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera Cytochrome b559 subunit alpha (psbE), partial CSB-YP607317VFQ1
CSB-EP607317VFQ1
CSB-BP607317VFQ1
CSB-MP607317VFQ1
CSB-EP607317VFQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera NAD (P)H-quinone oxidoreductase subunit 3, chloroplastic (ndhC), partial CSB-YP607318VFQ1
CSB-EP607318VFQ1
CSB-BP607318VFQ1
CSB-MP607318VFQ1
CSB-EP607318VFQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera Photosystem I P700 chlorophyll a apoprotein A1 (psaA), partial CSB-YP607319VFQ
CSB-EP607319VFQ
CSB-BP607319VFQ
CSB-MP607319VFQ
CSB-EP607319VFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera Photosystem II reaction center protein Z (psbZ), partial CSB-YP607320VFQ1
CSB-EP607320VFQ1
CSB-BP607320VFQ1
CSB-MP607320VFQ1
CSB-EP607320VFQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera DNA-directed RNA polymerase subunit beta' (rpoC2), partial CSB-YP607321VFQ
CSB-EP607321VFQ
CSB-BP607321VFQ
CSB-MP607321VFQ
CSB-EP607321VFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Pejvakin (PJVK) CSB-YP607322HU
CSB-EP607322HU
CSB-BP607322HU
CSB-MP607322HU
CSB-EP607322HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human coronavirus HKU1 Nucleoprotein (N) CSB-YP607323HIW
CSB-BP607323HIW
CSB-EP607323HIW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human coronavirus HKU1 Hemagglutinin-esterase (HE), partial CSB-YP607324HIW1
CSB-EP607324HIW1
CSB-BP607324HIW1
CSB-MP607324HIW1
CSB-EP607324HIW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hylobates lar Peptidyl-prolyl cis-trans isomerase A (PPIA) CSB-YP607325HXW
CSB-EP607325HXW
CSB-BP607325HXW
CSB-MP607325HXW
CSB-EP607325HXW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant ATP synthase subunit c, sodium ion specific (atpE), partial CSB-YP607326CBAF1
CSB-EP607326CBAF1
CSB-BP607326CBAF1
CSB-MP607326CBAF1
CSB-EP607326CBAF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative glycerophosphocholine phosphodiesterase GPCPD1 homolog T05H10.7 (T05H10.7), partial CSB-YP607327CXY
CSB-EP607327CXY
CSB-BP607327CXY
CSB-MP607327CXY
CSB-EP607327CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>